JPRN-UMIN000018122
Completed
未知
Intravitreal bevacizumab treatment for severe retinopathy of prematurity - Intravitreal bevacizumab treatment for severe retinopathy of prematurity
The Jikei University School of Medicine Department of Ophthalmology0 sites6 target enrollmentJune 29, 2015
Conditionssevere retinopathy of prematurity
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- severe retinopathy of prematurity
- Sponsor
- The Jikei University School of Medicine Department of Ophthalmology
- Enrollment
- 6
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with retinopathy of prematurity which are treatable by laser therapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The intravitreal injection of Bevacizumab for retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000028770Department of Ophthalmology, Shiga University of Medical Science24
Completed
Not Applicable
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurityJPRN-UMIN000014316Kansai Medical University15
Not yet recruiting
Not Applicable
Intravitreal Bevaxizumab injection for intraocular neovasculalization in childreretinopathy of prematurityJPRN-UMIN000007465Tokushima university hospital10
Recruiting
Not Applicable
Treatment with bevacizumab for ocular vascular lesionsOcular vascular lesionsJPRN-UMIN000020916Keio University, School of Medicine1,000
Withdrawn
Phase 3
Intravitreal Bevacizumab for Inflammatory Neovascular MembranesVogt Koyanagi Harada DiseaseSerpiginous ChoroiditisMultifocal ChoroiditisNCT00407121Asociación para Evitar la Ceguera en México